Fig. 2From: Medication use among patients with Crohn’s disease or ulcerative colitis before and after the initiation of advanced therapyStudy disposition and inclusion of patients in the UC cohort. AS ankylosing spondylitis, CD Crohn’s disease, DMARD disease-modifying antirheumatic drug, PsA psoriatic arthritis, RA rheumatoid arthritis, SLE systemic lupus erythematosus, UC ulcerative colitisBack to article page